{"id":"W4281766312","doi":"10.1200/jco.2022.40.16_suppl.533","title":"Outcomes of patients with T1a,b N0 Her2-positive breast cancer treated with adjuvant trastuzumab in a prospective registry in Ontario, Canada.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Febrile neutropenia; Trastuzumab; Cohort; Ejection fraction; Breast cancer; Cancer; Metastatic breast cancer; Surgery; Heart failure; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005198201,0.0003767657,0.0005018213,0.0007030174,0.001804459,0.0009664288,0.0009952869,0.0005456169,0.0009862939],"category_scores_gemma":[0.001357065,0.0004194403,0.0005914454,0.003265279,0.0006967614,0.0003270597,0.0006805381,0.0006666312,0.0001752634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02279113,"about_ca_system_score_gemma":0.02189699,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9656015,"about_ca_topic_score_gemma":0.9780994,"domain_scores_codex":[0.9992357,0.00005832715,0.0000582929,0.0001392344,0.0002590446,0.0002493327],"domain_scores_gemma":[0.9980049,0.00009151534,0.0007232156,0.00009821591,0.0005680543,0.0005140785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002621068,0.00003766706,0.9970368,0.00002313059,0.0000446447,0.0001406453,0.0002202684,0.00008163412,0.0001356839,0.00002950266,0.0008577952,0.001130267],"study_design_scores_gemma":[0.00004406407,0.00005854445,0.9988167,0.00001227527,0.00003401168,0.00008525888,0.0002486008,0.0001371943,0.00003720063,0.00001348868,0.000505419,0.000007173977],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901807,0.0006521227,0.0000576294,0.0003491978,0.000009618879,0.00008271792,0.007197035,0.000009127213,0.001461865],"genre_scores_gemma":[0.9960531,0.0003310353,0.00006307456,0.0001403107,0.000008011218,0.00003223466,0.002912315,0.000003365746,0.0004567152],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0343985,"threshold_uncertainty_score":0.165362,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02572389456721497,"score_gpt":0.3557218010343743,"score_spread":0.3299979064671594,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}